StockData
NervGen Pharma Corp. logo

NervGen Pharma Corp. (NGEN) stock

NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.90−0.06 (-3.06%)

Close on Nov 18, 2026Market cap $151.33MP/E –Yield –

NervGen Pharma r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was C$13.47M, down 13.2% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025C$13.47M-13.2%
FY2024Dec 31, 2024C$15.51M–

More NervGen Pharma figures

See a number that looks wrong?